Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study

INTRODUCTION: Approximately one third of all patients with cardiogenic shock suffer from acute kidney injury. Percutaneous coronary intervention, intra-aortic balloon pump, and continuous renal replacement therapy (CRRT) require effective antiplatelet therapy and anticoagulation, resulting in a high...

Descripción completa

Detalles Bibliográficos
Autores principales: Link, Andreas, Girndt, Matthias, Selejan, Simina, Rbah, Ranja, Böhm, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575600/
https://www.ncbi.nlm.nih.gov/pubmed/18759963
http://dx.doi.org/10.1186/cc6998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575600/
https://www.ncbi.nlm.nih.gov/pubmed/18759963
http://dx.doi.org/10.1186/cc6998

Ejemplares similares